All Articles

Early Phase 1 data for APR-1051 reveals anti-tumor activity and manageable safety, offering a new glimmer of hope for patients with advanced solid tumors.

With a new CEO and strong private equity backing, Vālenz Health is poised to accelerate its push into the booming self-funded healthcare market.

Revance unites its top acne treatment, PanOxyl, and microneedling device, SkinPen, in a strategic play to capture the holistic skincare market.

Anixa Biosciences secures a key Canadian patent for its novel ovarian cancer vaccine, advancing a new paradigm in cancer prevention for high-risk women.

After a five-year hiatus, the cult-favorite brand returns with a maximalist new look, challenging the reign of 'clean girl' beauty. Here's what's new.

Celebrating 10 years, Borrowell hits 4M members and 87M credit points gained. But how does its impact stack up in Canada's complex financial world?

MedtechWOMEN's VISION 2026 conference will address the industry's most pressing challenges, featuring leaders like Dr. Bayo Curry-Winchell and Martha Aronson.

A single blood test can now simultaneously track immune response, tumor changes, and resistance, offering new hope for personalizing sarcoma immunotherapy.

A new drug targeting cancer's 'immortality switch' enters a pivotal trial, offering hope for non-small cell lung cancer patients out of options.

The company is set to quadruple its cash-flowing assets in 2026, capitalizing on soaring demand for copper and tin essential for the energy transition.

Healthcare AI firm RAAPID achieves the 'gold standard' HITRUST r2 certification, signaling a major shift in data protection for sensitive patient information.

With $12M in new funding, Veritas Aortic Solutions aims to replace high-risk open-heart surgery with a groundbreaking transcatheter device for the aorta.

June is California Avocado Month! Dive into the state's peak season, supporting a $1.4B industry and discovering creative new ways to enjoy the fruit.

The Singaporean firm regained Nasdaq compliance but faces a strict one-year monitoring period, betting its future on key sustainable infrastructure projects.

Facing a severe cash crunch, Jasper Therapeutics is exploring a sale or even a shutdown, placing the future of its promising urticaria drug, briquilimab, in limbo.

Tradewinds Universal is moving to Las Vegas to build a public nightlife conglomerate. Can transparency legitimize an industry long kept in the shadows?

Nasdaq-listed TaoWeave invests in Manako Labs, shifting its focus from digital assets to the booming trillion-dollar Physical AI market.

Despite a sales dip from a soft housing market, flooring supplier Q.E.P. Co. boasts a strong balance sheet and growing share among professional contractors.

As AI projects stall in 'pilot purgatory,' ABnet launches a new suite to manage the infrastructure chaos and runaway costs hindering enterprise adoption.

With a major labor gap looming, ECO Canada's new funding for student placements offers a critical boost to employers and the future green workforce.